Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 25, 2003

View Archived Issues

CX-659S prevents rebound after prednisolone treatment

Effective use of sumatriptan in OCD

Good efficacy and safety profile established for atlizumab in rheumatoid arthritis

Antitumor effects described for SU-11654 in spontaneous canine tumors

Potential of levetiracetam in neuropathic pain

Genta acquires license to siRNA

Long-term efficacy of Retaane demonstrated in 24-month wet AMD trial

Fougera's lidocaine/prilocaine cream approved by FDA

NicOx and Merck sign research evaluation agreement for nitric oxide-donating drugs

IND filed for Atrigel formulation of octreotide

Fast track designation awarded to ABthrax

Merck & Co. discontinues development of first Karo Bio collaboration compound

Phase I bridging study of LEP-ETU commences

Levitra receives FDA approval

Thalidomide recommended for approval in Australia

Priority review for Vitrase NDA

Janssen patent covers prucalopride N-oxide isomers and their use

New acetylcholine receptor modulators in early development at Merck KGaA

Axovan scientists present novel antiobesity NPY Y5 antagonists

New PARP inhibitors and their use in ischemia-reperfusion injury

New alphavbeta3/alphavbeta5 antagonists prepared and tested at Bayer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...